Baker Bros. Advisors’s Dynavax Technologies DVAX Stock Holding History

Baker Bros. Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-75,000	Closed	-$429K	–	111
2019 Q4	$429K	Hold	75,000	–	–	﹤0.01%	98
2019 Q3	$268K	Hold	75,000	–	–	﹤0.01%	107
2019 Q2	$299K	Hold	75,000	–	–	﹤0.01%	102
2019 Q1	$548K	Hold	75,000	–	–	﹤0.01%	94
2018 Q4	$686K	Hold	75,000	–	–	0.01%	85
2018 Q3	$930K	Hold	75,000	–	–	0.01%	92
2018 Q2	$1.14M	Hold	75,000	–	–	0.01%	106
2018 Q1	$1.49M	Hold	75,000	–	–	0.01%	97
2017 Q4	$1.4M	Hold	75,000	–	–	0.01%	103
2017 Q3	$1.61M	Hold	75,000	–	–	0.01%	99
2017 Q2	$724K	Hold	75,000	–	–	0.01%	107
2017 Q1	$446K	Hold	75,000	–	–	﹤0.01%	113
2016 Q4	$296K	Hold	75,000	–	–	﹤0.01%	130
2016 Q3	$787K	Hold	75,000	–	–	0.01%	117
2016 Q2	$1.09M	Hold	75,000	–	–	0.01%	113
2016 Q1	$1.44M	Hold	75,000	–	–	0.02%	109
2015 Q4	$1.81M	Hold	75,000	–	–	0.02%	109
2015 Q3	$1.84M	Buy	+75,000	New	+$2.12M	0.02%	104

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCPEMI

Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baker Bros. Advisors's DVAX Position: Q1 2020 in Review

Baker Bros. Advisors sold out of Dynavax Technologies (DVAX) in Q1 2020, closing a stake of 75,000 shares — an estimated $429K sold.

Baker Bros. Advisors first reported a position in DVAX in Q3 2015 and held it in 18 quarters. The position peaked at $1.84M in Q3 2015. 113 funds tracked by Wall St. Rank hold DVAX as of Q1 2020.

Baker Bros. Advisors reported no remaining Dynavax Technologies position as of Q1 2020 after selling out during the quarter.
Baker Bros. Advisors sold 75,000 Dynavax Technologies shares in Q1 2020, an estimated $429K.
Baker Bros. Advisors first reported a position in Dynavax Technologies in Q3 2015 and held it in 18 quarters.
Baker Bros. Advisors's Dynavax Technologies position peaked at $1.84M in Q3 2015.
113 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2020.

Based on Baker Bros. Advisors's 13F filing for Q1 2020, filed 15 May 2020.